Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?
Marco Y. W. Zaki(Newcastle University), Helen L. Reeves(Newcastle upon Tyne Hospital), Despina Televantou(Aristotle University of Thessaloniki), Fiona Oakley(NIHR Newcastle Biomedical Research Centre), Maja Laszczewska(Newcastle University), Sari F. Alhasan(Newcastle University), Daniela Sia(Icahn School of Medicine at Mount Sinai), Jack Leslie(NIHR Newcastle Biomedical Research Centre), Misti McCain(Newcastle University), Gillian Patman(Newcastle University), Olivier Govaere(VIB-KU Leuven Center for Microbiology), Lee A. Borthwick(Newcastle University), Huw D. Thomas(Newcastle University), João Maurício(Newcastle University), Gary Beale(Epistem (United Kingdom)), Daniel Geh(Newcastle upon Tyne Hospitals NHS Foundation Trust), Dina Tiniakos(National and Kapodistrian University of Athens), Quentin M. Anstee(Newcastle upon Tyne Hospital), Lucy Gee(Newcastle University), Hannah L. Paish(Newcastle University), Anna Whitehead(University of Leeds), Alastair D. Burt(NIHR Newcastle Biomedical Research Centre), Ramy Younes(University of Turin), Ben S. Barksby(Newcastle University), Ruchi Shukla(Indian Institute of Technology BHU)
Cited by 20
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Serum markers detect the presence of liver fibrosis: A cohort study
|Gastroenterology|2004|1.1k